Immunopathogenetic and pharmacological aspects of interstitial lung diseases.

G. Mazzoccoli, A. De Cata, G. D. De Pinto, A. De Matthaeis, G. Vendemiale

Research output: Contribution to journalArticle

Abstract

Interstitial lung diseases (ILDs) are inflammatory diseases characterized by slow and progressive destruction of alveolar-capillary functional units, often leading to respiratory failure and death. A first stage of alveolitis and a following stage of fibrosis provoke an anatomical distortion of the peripheral airways and the interstitium, and for their smoldering evolution and non-specificity of symptoms ILDs may remain undiagnosed and untreated for a long time. In this review we exploited the immunopathogenetic aspects and the therapeutical approaches to this frequently unrecognized and severe disease.

Original languageEnglish
Pages (from-to)971-980
Number of pages10
JournalInternational Journal of Immunopathology and Pharmacology
Volume23
Issue number4
Publication statusPublished - Oct 2010

Fingerprint

Interstitial Lung Diseases
Pharmacology
Respiratory Insufficiency
Fibrosis

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Immunopathogenetic and pharmacological aspects of interstitial lung diseases. / Mazzoccoli, G.; De Cata, A.; De Pinto, G. D.; De Matthaeis, A.; Vendemiale, G.

In: International Journal of Immunopathology and Pharmacology, Vol. 23, No. 4, 10.2010, p. 971-980.

Research output: Contribution to journalArticle

@article{d8f442b1bfd84e1eb24d3ec39b84c7ae,
title = "Immunopathogenetic and pharmacological aspects of interstitial lung diseases.",
abstract = "Interstitial lung diseases (ILDs) are inflammatory diseases characterized by slow and progressive destruction of alveolar-capillary functional units, often leading to respiratory failure and death. A first stage of alveolitis and a following stage of fibrosis provoke an anatomical distortion of the peripheral airways and the interstitium, and for their smoldering evolution and non-specificity of symptoms ILDs may remain undiagnosed and untreated for a long time. In this review we exploited the immunopathogenetic aspects and the therapeutical approaches to this frequently unrecognized and severe disease.",
author = "G. Mazzoccoli and {De Cata}, A. and {De Pinto}, {G. D.} and {De Matthaeis}, A. and G. Vendemiale",
year = "2010",
month = "10",
language = "English",
volume = "23",
pages = "971--980",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "4",

}

TY - JOUR

T1 - Immunopathogenetic and pharmacological aspects of interstitial lung diseases.

AU - Mazzoccoli, G.

AU - De Cata, A.

AU - De Pinto, G. D.

AU - De Matthaeis, A.

AU - Vendemiale, G.

PY - 2010/10

Y1 - 2010/10

N2 - Interstitial lung diseases (ILDs) are inflammatory diseases characterized by slow and progressive destruction of alveolar-capillary functional units, often leading to respiratory failure and death. A first stage of alveolitis and a following stage of fibrosis provoke an anatomical distortion of the peripheral airways and the interstitium, and for their smoldering evolution and non-specificity of symptoms ILDs may remain undiagnosed and untreated for a long time. In this review we exploited the immunopathogenetic aspects and the therapeutical approaches to this frequently unrecognized and severe disease.

AB - Interstitial lung diseases (ILDs) are inflammatory diseases characterized by slow and progressive destruction of alveolar-capillary functional units, often leading to respiratory failure and death. A first stage of alveolitis and a following stage of fibrosis provoke an anatomical distortion of the peripheral airways and the interstitium, and for their smoldering evolution and non-specificity of symptoms ILDs may remain undiagnosed and untreated for a long time. In this review we exploited the immunopathogenetic aspects and the therapeutical approaches to this frequently unrecognized and severe disease.

UR - http://www.scopus.com/inward/record.url?scp=79953006950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953006950&partnerID=8YFLogxK

M3 - Article

C2 - 21244746

AN - SCOPUS:79953006950

VL - 23

SP - 971

EP - 980

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 4

ER -